Primary myelofibrosis: treatments, associated drugs and conditions

---

Number of reports submitted per year:

COVID vaccines that are associated with Primary myelofibrosis:

• Primary myelofibrosis in Moderna COVID Vaccine
• Primary myelofibrosis in Pfizer BioNTech Covid Vaccine
• Primary myelofibrosis in Johnson and Johnson Covid Vaccine

Primary myelofibrosis treatments and how effective are they?

• Hydrea
• Hydroxyurea
• Jakafi
• Revlimid

Common drugs associated with Primary myelofibrosis:

• Jakafi: 776 reports
• Aspirin: 275 reports
• Hydrea: 264 reports
• Lopurin: 171 reports
• Allopurinol: 171 reports
• Exjade: 156 reports
• Nplate: 155 reports
• Prednisone: 152 reports
• Hydroxyurea: 141 reports
• Prednisolone: 141 reports

All the drugs that are associated with Primary myelofibrosis:

• Primary myelofibrosis (1,090 drugs)

Common conditions associated with Primary myelofibrosis:

• High blood pressure: 141 reports
• Idiopathic thrombocytopenic purpura (itp): 108 reports

All the conditions that are associated with Primary myelofibrosis:

• Primary myelofibrosis (769 conditions)

Browse all Primary myelofibrosis symptoms:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Do you take any medication?

- You can start a phase IV clinical trial to monitor drug safety and effectiveness.

---

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all conditions on eHealthMe.